研究人员发现一种药物,即PMD-026,可能有效治疗血液癌,副作用较小。 Researchers discover a drug, PMD-026, may treat blood cancers effectively with low side effects.

华盛顿大学医学院的研究人员发现,在乳腺癌临床试验中,一种名为PMD-026的药物有可能治疗乳癌的血液癌,如宫颈增生肿瘤(MPNs)和具有攻击性的急性短血细胞白血病(AML)。 Researchers at Washington University School of Medicine found that a drug, PMD-026, in clinical trials for breast cancer, could potentially treat blood cancers like myeloproliferative neoplasms (MPNs) and aggressive acute myeloid leukemia (AML). 该药物的目标是一种叫RSK1的蛋白质,减少炎症并阻止癌症的继续。 The drug targets a protein called RSK1, reducing inflammation and halting cancer progression. 早期检测的副作用较低,为血液癌患者提供了新的治疗选择的希望。 Early tests show low side effects, raising hopes for a new treatment option for blood cancer patients.